APO Research

APO RESEARCH · REPORT

Digital Chronic Disease Management

Selected research

Industry Growth & Trends

Global Digital Chronic Disease Management Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Digital Chronic Disease Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Digital Chronic Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Digital Chronic Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Digital Chronic Disease Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Digital Chronic Disease Management market include S3 Connected Health, WellDoc, AstraZeneca, NTT DATA, Credo Health Services, Dawn Health, Bayer, Medtronic and Teladoc Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Digital Chronic Disease Management market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Digital Chronic Disease Management market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Digital Chronic Disease Management market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Digital Chronic Disease Management.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Digital Chronic Disease Management market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Digital Chronic Disease Management Market by Company

S3 Connected Health

WellDoc

AstraZeneca

NTT DATA

Credo Health Services

Dawn Health

Bayer

Medtronic

Teladoc Health

ScienceSoft

TriZetto Healthcare (Cognizant)

Omada Health

Phable

Pack Health

Epic Systems

Pathmate

EveryDose

Aptar Digital Health

VITech

ClouDr Group

JD Health

Ali Health

Ping An Good Doctor

We Doctor Group

Wei Mai

Medlinker

Digital Chronic Disease Management Segment by Type

Charge

Free

Digital Chronic Disease Management Segment by Application

Medical Institutions

Pharmacy

Chronic Disease Patients

Digital Chronic Disease Management Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Chronic Disease Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Chronic Disease Management and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Chronic Disease Management.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Digital Chronic Disease Management companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Digital Chronic Disease Management Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Digital Chronic Disease Management Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Digital Chronic Disease Management Market Share by Region (2021-2026) Table 4. Global Digital Chronic Disease Management Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Digital Chronic Disease Management Market Share by Region (2027-2032) Table 6. Global Digital Chronic Disease Management Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Digital Chronic Disease Management Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Digital Chronic Disease Management Market Size Share by Type (2021-2026) Table 9. Global Digital Chronic Disease Management Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Digital Chronic Disease Management Market Size Share Forecasted by Type (2027-2032) Table 11. North America Digital Chronic Disease Management Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Digital Chronic Disease Management Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Digital Chronic Disease Management Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Digital Chronic Disease Management Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Digital Chronic Disease Management Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Digital Chronic Disease Management Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Digital Chronic Disease Management Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Digital Chronic Disease Management Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Digital Chronic Disease Management Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Digital Chronic Disease Management Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Digital Chronic Disease Management Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Digital Chronic Disease Management Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Digital Chronic Disease Management Market Size Share by Application (2021-2026) Table 24. Global Digital Chronic Disease Management Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Digital Chronic Disease Management Market Size Share Forecasted by Application (2027-2032) Table 26. North America Digital Chronic Disease Management Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Digital Chronic Disease Management Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Digital Chronic Disease Management Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Digital Chronic Disease Management Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Digital Chronic Disease Management Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Digital Chronic Disease Management Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Digital Chronic Disease Management Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Digital Chronic Disease Management Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Digital Chronic Disease Management Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Digital Chronic Disease Management Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Digital Chronic Disease Management Industry Trends Table 37. Digital Chronic Disease Management Industry Drivers Table 38. Digital Chronic Disease Management Industry Opportunities and Challenges Table 39. Digital Chronic Disease Management Industry Restraints Table 40. Global Digital Chronic Disease Management Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Digital Chronic Disease Management Revenue Market Share by Company (2021-2026) Table 42. Global Digital Chronic Disease Management Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Digital Chronic Disease Management Key Company Headquarters & Area Served Table 44. Global Digital Chronic Disease Management Company, Product Type & Application Table 45. Global Digital Chronic Disease Management Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Digital Chronic Disease Management by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. S3 Connected Health Company Information Table 49. S3 Connected Health Business Overview Table 50. S3 Connected Health Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. S3 Connected Health Digital Chronic Disease Management Product Portfolio Table 52. S3 Connected Health Recent Development Table 53. WellDoc Company Information Table 54. WellDoc Business Overview Table 55. WellDoc Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. WellDoc Digital Chronic Disease Management Product Portfolio Table 57. WellDoc Recent Development Table 58. AstraZeneca Company Information Table 59. AstraZeneca Business Overview Table 60. AstraZeneca Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. AstraZeneca Digital Chronic Disease Management Product Portfolio Table 62. AstraZeneca Recent Development Table 63. NTT DATA Company Information Table 64. NTT DATA Business Overview Table 65. NTT DATA Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. NTT DATA Digital Chronic Disease Management Product Portfolio Table 67. NTT DATA Recent Development Table 68. Credo Health Services Company Information Table 69. Credo Health Services Business Overview Table 70. Credo Health Services Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Credo Health Services Digital Chronic Disease Management Product Portfolio Table 72. Credo Health Services Recent Development Table 73. Dawn Health Company Information Table 74. Dawn Health Business Overview Table 75. Dawn Health Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Dawn Health Digital Chronic Disease Management Product Portfolio Table 77. Dawn Health Recent Development Table 78. Bayer Company Information Table 79. Bayer Business Overview Table 80. Bayer Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Bayer Digital Chronic Disease Management Product Portfolio Table 82. Bayer Recent Development Table 83. Medtronic Company Information Table 84. Medtronic Business Overview Table 85. Medtronic Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Medtronic Digital Chronic Disease Management Product Portfolio Table 87. Medtronic Recent Development Table 88. Teladoc Health Company Information Table 89. Teladoc Health Business Overview Table 90. Teladoc Health Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Teladoc Health Digital Chronic Disease Management Product Portfolio Table 92. Teladoc Health Recent Development Table 93. ScienceSoft Company Information Table 94. ScienceSoft Business Overview Table 95. ScienceSoft Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. ScienceSoft Digital Chronic Disease Management Product Portfolio Table 97. ScienceSoft Recent Development Table 98. TriZetto Healthcare (Cognizant) Company Information Table 99. TriZetto Healthcare (Cognizant) Business Overview Table 100. TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Product Portfolio Table 102. TriZetto Healthcare (Cognizant) Recent Development Table 103. Omada Health Company Information Table 104. Omada Health Business Overview Table 105. Omada Health Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Omada Health Digital Chronic Disease Management Product Portfolio Table 107. Omada Health Recent Development Table 108. Phable Company Information Table 109. Phable Business Overview Table 110. Phable Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Phable Digital Chronic Disease Management Product Portfolio Table 112. Phable Recent Development Table 113. Pack Health Company Information Table 114. Pack Health Business Overview Table 115. Pack Health Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Pack Health Digital Chronic Disease Management Product Portfolio Table 117. Pack Health Recent Development Table 118. Epic Systems Company Information Table 119. Epic Systems Business Overview Table 120. Epic Systems Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Epic Systems Digital Chronic Disease Management Product Portfolio Table 122. Epic Systems Recent Development Table 123. Pathmate Company Information Table 124. Pathmate Business Overview Table 125. Pathmate Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Pathmate Digital Chronic Disease Management Product Portfolio Table 127. Pathmate Recent Development Table 128. EveryDose Company Information Table 129. EveryDose Business Overview Table 130. EveryDose Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. EveryDose Digital Chronic Disease Management Product Portfolio Table 132. EveryDose Recent Development Table 133. Aptar Digital Health Company Information Table 134. Aptar Digital Health Business Overview Table 135. Aptar Digital Health Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Aptar Digital Health Digital Chronic Disease Management Product Portfolio Table 137. Aptar Digital Health Recent Development Table 138. VITech Company Information Table 139. VITech Business Overview Table 140. VITech Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. VITech Digital Chronic Disease Management Product Portfolio Table 142. VITech Recent Development Table 143. ClouDr Group Company Information Table 144. ClouDr Group Business Overview Table 145. ClouDr Group Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. ClouDr Group Digital Chronic Disease Management Product Portfolio Table 147. ClouDr Group Recent Development Table 148. JD Health Company Information Table 149. JD Health Business Overview Table 150. JD Health Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. JD Health Digital Chronic Disease Management Product Portfolio Table 152. JD Health Recent Development Table 153. Ali Health Company Information Table 154. Ali Health Business Overview Table 155. Ali Health Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Ali Health Digital Chronic Disease Management Product Portfolio Table 157. Ali Health Recent Development Table 158. Ping An Good Doctor Company Information Table 159. Ping An Good Doctor Business Overview Table 160. Ping An Good Doctor Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Ping An Good Doctor Digital Chronic Disease Management Product Portfolio Table 162. Ping An Good Doctor Recent Development Table 163. We Doctor Group Company Information Table 164. We Doctor Group Business Overview Table 165. We Doctor Group Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. We Doctor Group Digital Chronic Disease Management Product Portfolio Table 167. We Doctor Group Recent Development Table 168. Wei Mai Company Information Table 169. Wei Mai Business Overview Table 170. Wei Mai Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. Wei Mai Digital Chronic Disease Management Product Portfolio Table 172. Wei Mai Recent Development Table 173. Medlinker Company Information Table 174. Medlinker Business Overview Table 175. Medlinker Digital Chronic Disease Management Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 176. Medlinker Digital Chronic Disease Management Product Portfolio Table 177. Medlinker Recent Development Table 178. North America Digital Chronic Disease Management Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. North America Digital Chronic Disease Management Market Size by Country (2021-2026) & (US$ Million) Table 180. North America Digital Chronic Disease Management Market Share by Country (2021-2026) Table 181. North America Digital Chronic Disease Management Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. North America Digital Chronic Disease Management Market Share Forecast by Country (2027-2032) Table 183. Europe Digital Chronic Disease Management Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Europe Digital Chronic Disease Management Market Size by Country (2021-2026) & (US$ Million) Table 185. Europe Digital Chronic Disease Management Market Share by Country (2021-2026) Table 186. Europe Digital Chronic Disease Management Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Europe Digital Chronic Disease Management Market Share Forecast by Country (2027-2032) Table 188. Asia-Pacific Digital Chronic Disease Management Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Asia-Pacific Digital Chronic Disease Management Market Size by Country (2021-2026) & (US$ Million) Table 190. Asia-Pacific Digital Chronic Disease Management Market Share by Country (2021-2026) Table 191. Asia-Pacific Digital Chronic Disease Management Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Asia-Pacific Digital Chronic Disease Management Market Share Forecast by Country (2027-2032) Table 193. Latin America Digital Chronic Disease Management Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Latin America Digital Chronic Disease Management Market Size by Country (2021-2026) & (US$ Million) Table 195. Latin America Digital Chronic Disease Management Market Share by Country (2021-2026) Table 196. Latin America Digital Chronic Disease Management Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Latin America Digital Chronic Disease Management Market Share Forecast by Country (2027-2032) Table 198. Middle East & Africa Digital Chronic Disease Management Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Middle East & Africa Digital Chronic Disease Management Market Size by Country (2021-2026) & (US$ Million) Table 200. Middle East & Africa Digital Chronic Disease Management Market Share by Country (2021-2026) Table 201. Middle East & Africa Digital Chronic Disease Management Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Middle East & Africa Digital Chronic Disease Management Market Share Forecast by Country (2027-2032) Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Digital Chronic Disease Management Product Image Figure 3. Global Digital Chronic Disease Management Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Digital Chronic Disease Management Market Size (2021-2032) & (US$ Million) Figure 5. Global Digital Chronic Disease Management Market Share by Region: 2025 VS 2032 Figure 6. Global Digital Chronic Disease Management Market Share by Region (2021-2032) Figure 7. North America Digital Chronic Disease Management Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Digital Chronic Disease Management Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Digital Chronic Disease Management Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Digital Chronic Disease Management Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Digital Chronic Disease Management Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Charge Image Figure 13. Global Charge Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Free Image Figure 15. Global Free Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Digital Chronic Disease Management Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Digital Chronic Disease Management Market Share by Type 2025 VS 2032 Figure 18. North America Digital Chronic Disease Management Market Size Share by Type (2021-2032) Figure 19. Europe Digital Chronic Disease Management Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Digital Chronic Disease Management Market Size Share by Type (2021-2032) Figure 21. Latin America Digital Chronic Disease Management Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Digital Chronic Disease Management Market Size Share by Type (2021-2032) Figure 23. Medical Institutions Image Figure 24. Global Medical Institutions Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Pharmacy Image Figure 26. Global Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Chronic Disease Patients Image Figure 28. Global Chronic Disease Patients Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Digital Chronic Disease Management Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Digital Chronic Disease Management Market Share by Application 2025 VS 2032 Figure 31. North America Digital Chronic Disease Management Market Size Share by Application (2021-2032) Figure 32. Europe Digital Chronic Disease Management Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Digital Chronic Disease Management Market Size Share by Application (2021-2032) Figure 34. Latin America Digital Chronic Disease Management Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Digital Chronic Disease Management Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Digital Chronic Disease Management Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Digital Chronic Disease Management Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Digital Chronic Disease Management Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Digital Chronic Disease Management Market Share by Country (2021-2032) Figure 41. Europe Digital Chronic Disease Management Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Digital Chronic Disease Management Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Digital Chronic Disease Management Market Share by Country (2021-2032) Figure 44. Asia-Pacific Digital Chronic Disease Management Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Digital Chronic Disease Management Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Digital Chronic Disease Management Market Share by Country (2021-2032) Figure 47. Latin America Digital Chronic Disease Management Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Digital Chronic Disease Management Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Digital Chronic Disease Management Market Share by Country (2021-2032) Figure 50. Middle East & Africa Digital Chronic Disease Management Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Digital Chronic Disease Management Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Digital Chronic Disease Management Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Charge
  • Free
Applications
  • Medical Institutions
  • Pharmacy
  • Chronic Disease Patients
Companies covered
  • S3 Connected Health
  • WellDoc
  • AstraZeneca
  • NTT DATA
  • Credo Health Services
  • Dawn Health
  • Bayer
  • Medtronic
  • Teladoc Health
  • ScienceSoft
  • TriZetto Healthcare (Cognizant)
  • Omada Health
  • Phable
  • Pack Health
  • Epic Systems
  • Pathmate
  • EveryDose
  • Aptar Digital Health
  • VITech
  • ClouDr Group
  • JD Health
  • Ali Health
  • Ping An Good Doctor
  • We Doctor Group
  • Wei Mai
  • Medlinker

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Digital Chronic Disease Management Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Digital Chronic Disease Management Market Size by Region (2021-2032)
  5. 1.4.1 Global Digital Chronic Disease Management Market Size by Region (2021-2026)
  6. 1.4.2 Global Digital Chronic Disease Management Market Size by Region (2027-2032)
  7. 1.5 Key Regions Digital Chronic Disease Management Market Size (2021-2032)
  8. 1.5.1 North America Digital Chronic Disease Management Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Digital Chronic Disease Management Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Digital Chronic Disease Management Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Digital Chronic Disease Management Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Digital Chronic Disease Management Market Size Growth Rate (2021-2032)
2 Digital Chronic Disease Management Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Charge
  3. 2.1.2 Free
  4. 2.2 Global Digital Chronic Disease Management Market Size by Type
  5. 2.2.1 Global Digital Chronic Disease Management Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Digital Chronic Disease Management Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Digital Chronic Disease Management Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Digital Chronic Disease Management Market Size by Regions
  9. 2.3.1 North America Digital Chronic Disease Management Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Digital Chronic Disease Management Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Digital Chronic Disease Management Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Digital Chronic Disease Management Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Digital Chronic Disease Management Market Size Breakdown by Type (2021-2026)
3 Digital Chronic Disease Management Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Medical Institutions
  3. 3.1.2 Pharmacy
  4. 3.1.3 Chronic Disease Patients
  5. 3.2 Global Digital Chronic Disease Management Market Size by Application
  6. 3.2.1 Global Digital Chronic Disease Management Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Digital Chronic Disease Management Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Digital Chronic Disease Management Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Digital Chronic Disease Management Market Size by Regions
  10. 3.3.1 North America Digital Chronic Disease Management Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Digital Chronic Disease Management Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Digital Chronic Disease Management Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Digital Chronic Disease Management Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Digital Chronic Disease Management Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Digital Chronic Disease Management Industry Trends
  2. 4.2 Digital Chronic Disease Management Industry Drivers
  3. 4.3 Digital Chronic Disease Management Industry Opportunities and Challenges
  4. 4.4 Digital Chronic Disease Management Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Digital Chronic Disease Management Revenue (2021-2026)
  2. 5.2 Global Digital Chronic Disease Management Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Digital Chronic Disease Management Key Company Headquarters & Area Served
  4. 5.4 Global Digital Chronic Disease Management Company, Product Type & Application
  5. 5.5 Global Digital Chronic Disease Management Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Digital Chronic Disease Management Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Digital Chronic Disease Management Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Digital Chronic Disease Management Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 S3 Connected Health
  2. 6.1.1 S3 Connected Health Company Information
  3. 6.1.2 S3 Connected Health Business Overview
  4. 6.1.3 S3 Connected Health Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 S3 Connected Health Digital Chronic Disease Management Product Portfolio
  6. 6.1.5 S3 Connected Health Recent Developments
  7. 6.2 WellDoc
  8. 6.2.1 WellDoc Company Information
  9. 6.2.2 WellDoc Business Overview
  10. 6.2.3 WellDoc Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 WellDoc Digital Chronic Disease Management Product Portfolio
  12. 6.2.5 WellDoc Recent Developments
  13. 6.3 AstraZeneca
  14. 6.3.1 AstraZeneca Company Information
  15. 6.3.2 AstraZeneca Business Overview
  16. 6.3.3 AstraZeneca Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 AstraZeneca Digital Chronic Disease Management Product Portfolio
  18. 6.3.5 AstraZeneca Recent Developments
  19. 6.4 NTT DATA
  20. 6.4.1 NTT DATA Company Information
  21. 6.4.2 NTT DATA Business Overview
  22. 6.4.3 NTT DATA Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 NTT DATA Digital Chronic Disease Management Product Portfolio
  24. 6.4.5 NTT DATA Recent Developments
  25. 6.5 Credo Health Services
  26. 6.5.1 Credo Health Services Company Information
  27. 6.5.2 Credo Health Services Business Overview
  28. 6.5.3 Credo Health Services Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Credo Health Services Digital Chronic Disease Management Product Portfolio
  30. 6.5.5 Credo Health Services Recent Developments
  31. 6.6 Dawn Health
  32. 6.6.1 Dawn Health Company Information
  33. 6.6.2 Dawn Health Business Overview
  34. 6.6.3 Dawn Health Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Dawn Health Digital Chronic Disease Management Product Portfolio
  36. 6.6.5 Dawn Health Recent Developments
  37. 6.7 Bayer
  38. 6.7.1 Bayer Company Information
  39. 6.7.2 Bayer Business Overview
  40. 6.7.3 Bayer Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Bayer Digital Chronic Disease Management Product Portfolio
  42. 6.7.5 Bayer Recent Developments
  43. 6.8 Medtronic
  44. 6.8.1 Medtronic Company Information
  45. 6.8.2 Medtronic Business Overview
  46. 6.8.3 Medtronic Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Medtronic Digital Chronic Disease Management Product Portfolio
  48. 6.8.5 Medtronic Recent Developments
  49. 6.9 Teladoc Health
  50. 6.9.1 Teladoc Health Company Information
  51. 6.9.2 Teladoc Health Business Overview
  52. 6.9.3 Teladoc Health Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Teladoc Health Digital Chronic Disease Management Product Portfolio
  54. 6.9.5 Teladoc Health Recent Developments
  55. 6.10 ScienceSoft
  56. 6.10.1 ScienceSoft Company Information
  57. 6.10.2 ScienceSoft Business Overview
  58. 6.10.3 ScienceSoft Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 ScienceSoft Digital Chronic Disease Management Product Portfolio
  60. 6.10.5 ScienceSoft Recent Developments
  61. 6.11 TriZetto Healthcare (Cognizant)
  62. 6.11.1 TriZetto Healthcare (Cognizant) Company Information
  63. 6.11.2 TriZetto Healthcare (Cognizant) Business Overview
  64. 6.11.3 TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Product Portfolio
  66. 6.11.5 TriZetto Healthcare (Cognizant) Recent Developments
  67. 6.12 Omada Health
  68. 6.12.1 Omada Health Company Information
  69. 6.12.2 Omada Health Business Overview
  70. 6.12.3 Omada Health Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Omada Health Digital Chronic Disease Management Product Portfolio
  72. 6.12.5 Omada Health Recent Developments
  73. 6.13 Phable
  74. 6.13.1 Phable Company Information
  75. 6.13.2 Phable Business Overview
  76. 6.13.3 Phable Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Phable Digital Chronic Disease Management Product Portfolio
  78. 6.13.5 Phable Recent Developments
  79. 6.14 Pack Health
  80. 6.14.1 Pack Health Company Information
  81. 6.14.2 Pack Health Business Overview
  82. 6.14.3 Pack Health Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Pack Health Digital Chronic Disease Management Product Portfolio
  84. 6.14.5 Pack Health Recent Developments
  85. 6.15 Epic Systems
  86. 6.15.1 Epic Systems Company Information
  87. 6.15.2 Epic Systems Business Overview
  88. 6.15.3 Epic Systems Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Epic Systems Digital Chronic Disease Management Product Portfolio
  90. 6.15.5 Epic Systems Recent Developments
  91. 6.16 Pathmate
  92. 6.16.1 Pathmate Company Information
  93. 6.16.2 Pathmate Business Overview
  94. 6.16.3 Pathmate Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Pathmate Digital Chronic Disease Management Product Portfolio
  96. 6.16.5 Pathmate Recent Developments
  97. 6.17 EveryDose
  98. 6.17.1 EveryDose Company Information
  99. 6.17.2 EveryDose Business Overview
  100. 6.17.3 EveryDose Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 EveryDose Digital Chronic Disease Management Product Portfolio
  102. 6.17.5 EveryDose Recent Developments
  103. 6.18 Aptar Digital Health
  104. 6.18.1 Aptar Digital Health Company Information
  105. 6.18.2 Aptar Digital Health Business Overview
  106. 6.18.3 Aptar Digital Health Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Aptar Digital Health Digital Chronic Disease Management Product Portfolio
  108. 6.18.5 Aptar Digital Health Recent Developments
  109. 6.19 VITech
  110. 6.19.1 VITech Company Information
  111. 6.19.2 VITech Business Overview
  112. 6.19.3 VITech Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 VITech Digital Chronic Disease Management Product Portfolio
  114. 6.19.5 VITech Recent Developments
  115. 6.20 ClouDr Group
  116. 6.20.1 ClouDr Group Company Information
  117. 6.20.2 ClouDr Group Business Overview
  118. 6.20.3 ClouDr Group Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 ClouDr Group Digital Chronic Disease Management Product Portfolio
  120. 6.20.5 ClouDr Group Recent Developments
  121. 6.21 JD Health
  122. 6.21.1 JD Health Company Information
  123. 6.21.2 JD Health Business Overview
  124. 6.21.3 JD Health Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 JD Health Digital Chronic Disease Management Product Portfolio
  126. 6.21.5 JD Health Recent Developments
  127. 6.22 Ali Health
  128. 6.22.1 Ali Health Company Information
  129. 6.22.2 Ali Health Business Overview
  130. 6.22.3 Ali Health Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Ali Health Digital Chronic Disease Management Product Portfolio
  132. 6.22.5 Ali Health Recent Developments
  133. 6.23 Ping An Good Doctor
  134. 6.23.1 Ping An Good Doctor Company Information
  135. 6.23.2 Ping An Good Doctor Business Overview
  136. 6.23.3 Ping An Good Doctor Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Ping An Good Doctor Digital Chronic Disease Management Product Portfolio
  138. 6.23.5 Ping An Good Doctor Recent Developments
  139. 6.24 We Doctor Group
  140. 6.24.1 We Doctor Group Company Information
  141. 6.24.2 We Doctor Group Business Overview
  142. 6.24.3 We Doctor Group Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 We Doctor Group Digital Chronic Disease Management Product Portfolio
  144. 6.24.5 We Doctor Group Recent Developments
  145. 6.25 Wei Mai
  146. 6.25.1 Wei Mai Company Information
  147. 6.25.2 Wei Mai Business Overview
  148. 6.25.3 Wei Mai Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 Wei Mai Digital Chronic Disease Management Product Portfolio
  150. 6.25.5 Wei Mai Recent Developments
  151. 6.26 Medlinker
  152. 6.26.1 Medlinker Company Information
  153. 6.26.2 Medlinker Business Overview
  154. 6.26.3 Medlinker Digital Chronic Disease Management Revenue, Global Share and Gross Margin (2021-2026)
  155. 6.26.4 Medlinker Digital Chronic Disease Management Product Portfolio
  156. 6.26.5 Medlinker Recent Developments
7 North America
  1. 7.1 North America Digital Chronic Disease Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Digital Chronic Disease Management Market Size by Country (2021-2026)
  3. 7.3 North America Digital Chronic Disease Management Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Digital Chronic Disease Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Digital Chronic Disease Management Market Size by Country (2021-2026)
  3. 8.3 Europe Digital Chronic Disease Management Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Digital Chronic Disease Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Digital Chronic Disease Management Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Digital Chronic Disease Management Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Digital Chronic Disease Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Digital Chronic Disease Management Market Size by Country (2021-2026)
  3. 10.3 South America Digital Chronic Disease Management Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Digital Chronic Disease Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Digital Chronic Disease Management Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Digital Chronic Disease Management Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research